Lamotrigin Aristo (Lamotrigine)

Lamotrigine is used in the management of seizure disorders and mood stabilization, acting on neuronal excitability.

• Partial seizures: reduces frequency and severity of focal onset seizures.
• Generalized tonic‑clonic seizures: helps prevent convulsive episodes in patients with generalized epilepsy.
• Bipolar disorder: stabilizes mood and decreases the risk of manic or depressive episodes.

• Lamotrigine inhibits voltage‑gated sodium channels, which decreases the rapid influx of sodium ions during neuronal depolarization. This stabilizes neuronal membranes, limits repetitive firing, and reduces the release of excitatory neurotransmitters such as glutamate. By modulating these pathways, the drug diminishes abnormal electrical activity that underlies seizures and contributes to mood regulation in bipolar disorder. The effect is dose‑dependent and contributes to its therapeutic profile across the approved indications.

Lamotrigin Aristo may be associated with a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects

• Dizziness: sensation of light‑headedness or unsteadiness.
• Headache: mild to moderate cranial pain.
• Nausea: feeling of stomach upset, sometimes with vomiting.
• Rash: mild skin redness or itching.

Serious or Rare Side Effects

• Stevens‑Johnson syndrome: severe skin reaction with blistering and mucosal involvement.
• Aseptic meningitis: inflammation of the meninges without bacterial infection, presenting with headache and fever.
• Blood dyscrasias: rare cases of agranulocytosis or aplastic anemia.

When prescribing Lamotrigin Aristo, clinicians should observe several precautionary measures to ensure safe use.

• Dose titration: increase gradually to minimize rash risk.
• Renal impairment: adjust dose in patients with reduced kidney function.
• Concomitant valproate: avoid rapid titration as it raises lamotrigine levels.
• Pregnancy: weigh benefits against potential fetal risks; consult specialist.
• Drug‑induced skin reactions: discontinue immediately if severe rash develops.
• Store at ambient temperature: keep below 25 °C in original container, protect from moisture and light.

Lamotrigin Aristo can interact with several medicines, altering its plasma concentration or increasing adverse effect risk.

Major Interactions (Avoid)

• Valproic acid: markedly increases lamotrigine levels; avoid co‑administration or use reduced dose.
• Carbamazepine: reduces lamotrigine concentrations, potentially decreasing efficacy.
• Phenobarbital: induces metabolism leading to lower lamotrigine exposure.
• Phenytoin: accelerates clearance, requiring dose adjustment.
• Oral contraceptives: may lower lamotrigine levels, risking breakthrough seizures.

Moderate Interactions (Monitor Closely)

• Serotonergic agents: combined use may increase risk of serotonin syndrome.
• Other antiepileptics (e.g., levetiracetam): monitor seizure control.
• Antidepressants (SSRIs): observe for increased dizziness or rash.